# A Study of Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy

> **NCT02942381** · PHASE2 · COMPLETED · sponsor: **Peking University First Hospital** · enrollment: 60 (actual)

## Conditions studied

- IgA Patients
- Hydroxychloroquine

## Interventions

- **DRUG:** Hydroxychloroquine Sulfate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02942381
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-13
- **Primary completion:** 2018-01-08
- **Final completion:** 2018-01-08
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2018-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02942381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02942381, "A Study of Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02942381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*